Cargando…
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
Survival of patients with acute myeloid leukemia (AML) is inversely associated with age, but the impact of race on outcomes of adolescent and young adult (AYA; range, 18-39 years) patients is unknown. We compared survival of 89 non-Hispanic Black and 566 non-Hispanic White AYA patients with AML trea...
Autores principales: | Larkin, Karilyn T., Nicolet, Deedra, Kelly, Benjamin J., Mrózek, Krzysztof, LaHaye, Stephanie, Miller, Katherine E., Wijeratne, Saranga, Wheeler, Gregory, Kohlschmidt, Jessica, Blachly, James S., Mims, Alice S., Walker, Christopher J., Oakes, Christopher C., Orwick, Shelley, Boateng, Isaiah, Buss, Jill, Heyrosa, Adrienne, Desai, Helee, Carroll, Andrew J., Blum, William, Powell, Bayard L., Kolitz, Jonathan E., Moore, Joseph O., Mayer, Robert J., Larson, Richard A., Stone, Richard M., Paskett, Electra D., Byrd, John C., Mardis, Elaine R., Eisfeld, Ann-Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577622/ https://www.ncbi.nlm.nih.gov/pubmed/35788257 http://dx.doi.org/10.1182/bloodadvances.2022007544 |
Ejemplares similares
-
Association of social deprivation with survival in younger adult patients with AML: an Alliance study
por: Rebechi, Melanie, et al.
Publicado: (2023) -
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
por: Mrózek, Krzysztof, et al.
Publicado: (2023) -
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
por: Fobare, Sydney, et al.
Publicado: (2022) -
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
por: Eisfeld, Ann-Kathrin, et al.
Publicado: (2018) -
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
por: Bhatnagar, Bhavana, et al.
Publicado: (2023)